Prostalund Ab Stock Five Year Return
PLUN Stock | SEK 8.40 0.60 6.67% |
ProstaLund AB fundamentals help investors to digest information that contributes to ProstaLund's financial success or failures. It also enables traders to predict the movement of ProstaLund Stock. The fundamental analysis module provides a way to measure ProstaLund's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ProstaLund stock.
ProstaLund |
ProstaLund AB Company Five Year Return Analysis
ProstaLund's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
According to the company disclosure, ProstaLund AB has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Medical Care Facilities (which currently averages 0.0) industry. This indicator is about the same for all Sweden stocks average (which is currently at 0.0).
Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
All Next | Launch Module |
ProstaLund Fundamentals
Return On Equity | -0.25 | |||
Return On Asset | -0.13 | |||
Profit Margin | (0.61) % | |||
Operating Margin | (0.59) % | |||
Current Valuation | 215.81 M | |||
Shares Outstanding | 57.19 M | |||
Shares Owned By Insiders | 50.77 % | |||
Shares Owned By Institutions | 1.93 % | |||
Price To Book | 5.09 X | |||
Price To Sales | 13.54 X | |||
Revenue | 17.07 M | |||
Gross Profit | 14.68 M | |||
EBITDA | (7.54 M) | |||
Net Income | (7.88 M) | |||
Cash And Equivalents | 19.11 M | |||
Cash Per Share | 2.98 X | |||
Current Ratio | 6.11 X | |||
Book Value Per Share | 0.79 X | |||
Cash Flow From Operations | (5.8 M) | |||
Earnings Per Share | (0.17) X | |||
Beta | 0.84 | |||
Market Capitalization | 248.19 M | |||
Total Asset | 43.48 M | |||
Retained Earnings | 19 M | |||
Current Asset | 27 M | |||
Current Liabilities | 4 M | |||
Net Asset | 43.48 M |
About ProstaLund Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ProstaLund AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProstaLund using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProstaLund AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ProstaLund Stock Analysis
When running ProstaLund's price analysis, check to measure ProstaLund's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProstaLund is operating at the current time. Most of ProstaLund's value examination focuses on studying past and present price action to predict the probability of ProstaLund's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProstaLund's price. Additionally, you may evaluate how the addition of ProstaLund to your portfolios can decrease your overall portfolio volatility.